BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 10069701)

  • 1. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostaglandins and nitric oxide in the lipopolysaccharide-induced ACTH and corticosterone response.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2004 Sep; 55(3):663-75. PubMed ID: 15381835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation by nitric oxide of the carbachol-induced corticosterone secretion in rats.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1997 Jun; 48(2):277-84. PubMed ID: 9223031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamie-pituitary-adrenal response during crowding stress.
    Bugajski AJ; Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2006 Sep; 57(3):463-77. PubMed ID: 17033098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1999 Jun; 50(2):327-34. PubMed ID: 10424727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in the nicotine-induced pituitary-adrenocortical response.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2004 Jun; 55(2):443-55. PubMed ID: 15213364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and prostaglandin systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones.
    Bugajski J; Gadek-Michalska A; Bugajski AJ
    J Physiol Pharmacol; 2004 Dec; 55(4):679-703. PubMed ID: 15613736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13.
    Jászberényi M; Bujdosó E; Telegdy G
    Neuroscience; 2004; 129(3):811-6. PubMed ID: 15541902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of N-nitro-L-arginine methyl ester on cocaine-induced hormonal changes in mice.
    Budziszewska B; Leśkiewicz M; Jaworska-Feil L; Lasoń W
    Exp Clin Endocrinol Diabetes; 1998; 106(4):340-5. PubMed ID: 9792468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and prostaglandins in the clenbuterol-induced ACTH and corticosterone secretion.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Mar; 59(1):163-75. PubMed ID: 18441396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide in the adrenergic-and CRH-induced activation of hypothalamic-pituitary-adrenal axis.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2008 Jun; 59(2):365-78. PubMed ID: 18622051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
    Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclooxygenase inhibitors on the vasopressin induced ACTH and corticosterone response during crowding stress.
    Bugajski J; Gadek-Michalska A
    J Physiol Pharmacol; 2003 Jun; 54(2):247-56. PubMed ID: 12832725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity.
    Gadek-Michalska A; Bugajski J; Bugajski AJ; Głód R
    J Physiol Pharmacol; 2002 Jun; 53(2):275-87. PubMed ID: 12120902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of N-nitro-L-arginine methyl ester on morphine-induced changes in the plasma corticosterone and testosterone levels in mice.
    Budziszewska B; Leśkiewicz M; Jaworska-Feil L; Lasoń W
    Exp Clin Endocrinol Diabetes; 1999; 107(1):75-9. PubMed ID: 10077360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide in the vasopressin-induced corticosterone secretion in rats.
    Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R
    J Physiol Pharmacol; 1997 Dec; 48(4):805-12. PubMed ID: 9444626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.